Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00499252 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

NETWORK

Sponsor class

Conditions

Fallopian Tube Carcinoma
Primary Peritoneal Carcinoma
Recurrent Ovarian Carcinoma

Interventions

DRUG: Paclitaxel Albumin-Stabilized Nanoparticle Formulation

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]